SCHEMBL3567251

SCHEMBL3567251

O=C1NCc2ccccc2/C1=C\Nc1ccc(CCN2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.41
SIGMAR1 Q99720 4/20 0.40
PARP1 P09874 1/20 0.39
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
DRD2 P14416 3/20 0.38
HTR2A P28223 3/20 0.38
HTR2C P28335 3/20 0.38
HTR2B P41595 3/20 0.38
HRH3 Q9Y5N1 6/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MBTD1 Q05BQ5 1/20 0.37
L3MBTL3 Q96JM7 1/20 0.37
PLK1 P53350 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
RET P07949 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3567253 1.00 SLC6A3 (0.41) SLC6A3SIGMAR1PARP1CA12CA9
SCHEMBL13343966 1.00 SLC6A3 (0.41) SLC6A3SIGMAR1PARP1CA12CA9
SCHEMBL3572943 0.88 PARP1 (0.44) PARP1CA12CA9HRH3
SCHEMBL13343954 0.88 PARP1 (0.44) PARP1CA12CA9HRH3
SCHEMBL3572941 0.88 PARP1 (0.44) PARP1CA12CA9HRH3
SCHEMBL3567970 0.84 SLC6A3 (0.43) SLC6A3SIGMAR1PARP1DRD2HTR2A
SCHEMBL3567973 0.84 SLC6A3 (0.43) SLC6A3SIGMAR1PARP1DRD2HTR2A
SCHEMBL4994566 0.82 ERBB2 (0.45) SLC6A3SIGMAR1HRH3
SCHEMBL4994561 0.82 ERBB2 (0.45) SLC6A3SIGMAR1HRH3
SCHEMBL3570643 0.80 ERBB2 (0.45) CA12CA9L3MBTL1TDP1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 SLC6A3 367/4885SIGMAR1 636/4885PARP1 1048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.